TY - JOUR
T1 - The role of tobacco in cancer health disparities
AU - Vidrine, Jennifer Irvin
AU - Reitzel, Lorraine R.
AU - Wetter, David W.
N1 - Funding Information:
This research and preparation of this manuscript were partially supported by grants from the Centers for Disease Control and Prevention (R18DP001570 and K01DP001120), the National Cancer Institute (R01CA125413, R01CA094826, and R01CA089350), and the National Institute on Drug Abuse (R01DA014818).
PY - 2009
Y1 - 2009
N2 - Although public health efforts have dramatically reduced the prevalence of smoking in the past several decades, smoking remains the leading cause of preventable morbidity and mortality in the United States. Moreover, tobacco use is becoming increasingly concentrated among individuals with the lowest levels of education, income, and occupational status. Profound racial/ethnic and socioeconomic status (SES) disparities exist for tobacco-related cancer incidence and mortality, and for access to and quality of cancer treatment. Furthermore, racial/ethnic minority and low SES smokers have greater difficulty quitting smoking, are less likely to use effective resources for quitting, and have limited access to evidence-based cessation treatments. Widespread implementation of population-based tobacco cessation approaches may have had the unintended effect of increasing tobacco-related cancer health disparities. It is crucial that vulnerable populations of smokers be provided with effective and accessible treatments for tobacco dependence, as this would have a profound impact on reducing tobacco-related cancer health disparities.
AB - Although public health efforts have dramatically reduced the prevalence of smoking in the past several decades, smoking remains the leading cause of preventable morbidity and mortality in the United States. Moreover, tobacco use is becoming increasingly concentrated among individuals with the lowest levels of education, income, and occupational status. Profound racial/ethnic and socioeconomic status (SES) disparities exist for tobacco-related cancer incidence and mortality, and for access to and quality of cancer treatment. Furthermore, racial/ethnic minority and low SES smokers have greater difficulty quitting smoking, are less likely to use effective resources for quitting, and have limited access to evidence-based cessation treatments. Widespread implementation of population-based tobacco cessation approaches may have had the unintended effect of increasing tobacco-related cancer health disparities. It is crucial that vulnerable populations of smokers be provided with effective and accessible treatments for tobacco dependence, as this would have a profound impact on reducing tobacco-related cancer health disparities.
UR - http://www.scopus.com/inward/record.url?scp=70350142696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350142696&partnerID=8YFLogxK
U2 - 10.1007/s11912-009-0064-9
DO - 10.1007/s11912-009-0064-9
M3 - Review article
C2 - 19840525
AN - SCOPUS:70350142696
SN - 1523-3790
VL - 11
SP - 475
EP - 481
JO - Current oncology reports
JF - Current oncology reports
IS - 6
ER -